SEC restatements
BioNexus Gene Lab Corp (BGLC)
BioNexus Gene Lab Corp has 9 revised figures in later SEC filings: annual figures whose value in a later filing differs from the value on record first. Each revision below links to both filings.
CIK 0001737523
Most recent revisions
Newest 3 of 9 · as filed · by the latest filing stating each revision
| Figure | On record first | Revised |
|---|---|---|
| Financing cash flowPeriod ended Dec 31, 2024 | $144.97KFiled Apr 15, 2025 (opens EDGAR in a new tab) | $3.98KFiled Apr 14, 2026 (opens EDGAR in a new tab) |
| Operating cash flowPeriod ended Dec 31, 2024 | $-2.23MFiled Apr 15, 2025 (opens EDGAR in a new tab) | $-2.09MFiled Apr 14, 2026 (opens EDGAR in a new tab) |
| CapExPeriod ended Dec 31, 2023 | $18.00Filed Apr 16, 2024 (opens EDGAR in a new tab) | $149.40KFiled Apr 15, 2025 (opens EDGAR in a new tab) |
A revised figure is not by itself a correction of an error. Companies re-present prior figures for ordinary reasons too, such as a discontinued business, a merger or a new accounting standard. The value on record first is the earliest filing we hold that states the figure; the revised value is the latest revised value on record, linked to the latest filing that states it.
revised annual figures for BioNexus Gene Lab Corp
This page shows the most recent 3. The complete list, every revised figure with both values and both filings, is in the API and the MCP server (get_revisions) on the Analyst plan.
Programmatic access
Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.
- Every revised figure for this company, with both values and both filings (Analyst)
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/revisions/BGLC
MCP tool:
get_revisions ticker=BGLC
Not investment advice. Figures are shown as filed with the SEC; each one links to the filing it came from.